These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 164185)

  • 1. An effect of glucagon on 3', 5'-cyclic AMP phosphodiesterase activity in isolated rat hepatocytes.
    Allan EH; Sneyd JG
    Biochem Biophys Res Commun; 1975 Feb; 62(3):594-601. PubMed ID: 164185
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of cyclic AMP metabolism in rat liver. A correlative study of tissue levels of cyclic AMP, accumulation of cyclic AMP in slices, adenylate cyclase activity and cyclic nucleotide phosphodiesterase activity.
    Christoffersen T; Morland J; Osnes JB; Oye I
    Biochim Biophys Acta; 1973 Jul; 313(2):338-49. PubMed ID: 4354955
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of glucagon, dibutyryl adenosine 3',5'-cyclic monophosphate and phosphodiesterase inhibitors on rat liver phosphorylase activity and adenosine 3',5'-cyclic monophosphate levels.
    Ingebretsen C; Clark JF; Allen DO; Ashmore J
    Biochem Pharmacol; 1974 Aug; 23(15):2139-46. PubMed ID: 4369954
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasopressin and angiotensin control the activity of liver phosphodiesterase.
    Keppens S; De Wulf H
    Biochem J; 1984 Aug; 222(1):277-80. PubMed ID: 6089761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lithium on glucagon-stimulated cyclic AMP excretion in rats.
    Olesen OV; Jensen J; Thomsen K
    Acta Pharmacol Toxicol (Copenh); 1974 Nov; 35(5):403-11. PubMed ID: 4372858
    [No Abstract]   [Full Text] [Related]  

  • 6. An assessment of phosphodiesterase activity in situ after treatment of hepatocytes with hormones.
    Gettys TW; Blackmore PF; Corbin JD
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E449-53. PubMed ID: 2833111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of thyroxine on the contents of cyclic AMP and on the activity of cyclic AMP phosphodiesterase in hepatocytes of the rat].
    Leoni S; Spagnuolo S
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1874-8. PubMed ID: 182190
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of glucagon on cyclic AMP and carbohydrate metabolism in livers from diabetic rats.
    Pilkis SJ; Exton JH; Johnson RA; Park CR
    Biochim Biophys Acta; 1974 Mar; 343(1):250-67. PubMed ID: 4364131
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of a plasma membrane phosphodiesterase in the negative control of cyclic AMP levels by vasopressin in rat hepatocytes.
    Miot F; Keppens S; Erneux C; Wells JN; De Wulf H
    Biochem Pharmacol; 1988 Sep; 37(18):3447-53. PubMed ID: 2844189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection-induced hyperglucagonemia and altered hepatic response to glucagon in the rat.
    Zenser TV; DeRubertis FR; George DT; Rayfield EJ
    Am J Physiol; 1974 Dec; 227(6):1299-305. PubMed ID: 4155248
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of glucagon and prostaglandin E1 on cyclic AMP levels in liver of heat exposed hamsters.
    Aharon M; Graziani Y; Chayoth R
    Acta Endocrinol (Copenh); 1980 Apr; 93(4):475-8. PubMed ID: 6247868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness to glucagon by isolated rat hepatocytes controlled by the redox state of the cytosolic nicotinamide--adenine dinucleotide couple acting on adenosine 3':5'-cyclic monophosphate phosphodiesterase.
    Clark MG; Jarrett IG
    Biochem J; 1978 Dec; 176(3):805-16. PubMed ID: 218554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-sensitive adenosine 3',5'-cyclic monophosphate phosphodiesterase of hepatocyte plasma membrane.
    Tria E; Scapin S; Cocco C; Luly P
    Biochim Biophys Acta; 1977 Jan; 496(1):77-87. PubMed ID: 189834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethanol and lactate on the basal and glucagon-activated cyclic AMP formation in isolated hepatocytes.
    Zederman R; Löw H; Hall K
    FEBS Lett; 1977 Mar; 75(1):291-4. PubMed ID: 192590
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of glucocorticoid enhancement of the capacity of hepatocytes to accumulate cyclic AMP.
    Thoresen GH; Gjone IH; Gladhaug IP; Refsnes M; Ostby E; Christoffersen T
    Pharmacol Toxicol; 1989 Sep; 65(3):175-80. PubMed ID: 2478993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective phosphodiesterase 3 inhibition in the perfused liver of the rat after endotoxin treatment.
    Weidenbach H; Beckh K; Burger M; Schricker T; Georgieff M; Adler G
    Br J Pharmacol; 1996 Jun; 118(3):790-6. PubMed ID: 8762109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the novel rat liver IBMX-insensitive phosphodiesterase as a non-specific phosphodiesterase capable of hydrolysing cCMP.
    Worby A; Mensah LM; Murray KJ
    Biochem Pharmacol; 1991 Aug; 42(6):1318-21. PubMed ID: 1716099
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormonal control of phenylalanine hydroxylase activity in isolated rat hepatocytes.
    Abita JP; Chamras H; Rosselin G; Rey F
    Biochem Biophys Res Commun; 1980 Feb; 92(3):912-8. PubMed ID: 6244820
    [No Abstract]   [Full Text] [Related]  

  • 19. Isoproterenol and glucagon effects in perfused hearts from spontaneously hypertensive and normotensive rats.
    Largis EE; Allen DO; Clark J; Ashmore J
    Biochem Pharmacol; 1973 Jul; 22(14):1735-44. PubMed ID: 4351901
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of glucagon, phosphodiesterase inhibitors, and trypsin treatment on cyclic 3',5' adenosine monophosphate levels in isolated hepatocytes.
    Moxley MA; Allen DO
    Horm Metab Res; 1975 Jul; 7(4):330-4. PubMed ID: 168140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.